Chondrodysplasia punctata
Chondrodysplasia punctata is a rare genetic disorder characterized by abnormal development of the bones and cartilage. The term "chondrodysplasia punctata" refers to the punctate calcification, or stippling, that occurs in the cartilage of individuals with this disorder. This stippling is most commonly observed in the long bones and vertebrae, but can also be present in other areas of the body.
Etiology[edit | edit source]
Chondrodysplasia punctata can be caused by a variety of genetic mutations. The most common form of the disorder, known as X-linked dominant chondrodysplasia punctata (CDPX1), is caused by mutations in the ARL6IP5 gene. This gene provides instructions for making a protein that is involved in the formation and maintenance of peroxisomes, which are small structures within cells that break down toxic substances and synthesize lipids necessary for cell function.
Symptoms[edit | edit source]
Symptoms of chondrodysplasia punctata can vary widely, but often include short stature, skeletal abnormalities, cleft palate, cataracts, hearing loss, and intellectual disability. Some individuals may also have skin abnormalities, such as ichthyosis (a condition that causes dry, scaly skin) or alopecia (hair loss).
Diagnosis[edit | edit source]
Diagnosis of chondrodysplasia punctata is typically based on the presence of characteristic clinical features and radiographic findings. Genetic testing can confirm the diagnosis and identify the specific gene mutation causing the disorder.
Treatment[edit | edit source]
There is currently no cure for chondrodysplasia punctata, and treatment is symptomatic and supportive. This may include physical therapy, surgery to correct bone abnormalities, and management of other medical complications.
Prognosis[edit | edit source]
The prognosis for individuals with chondrodysplasia punctata varies depending on the severity of symptoms and the presence of other health problems. Some individuals with mild symptoms live into adulthood, while those with severe forms of the disorder may have a shortened lifespan due to complications such as respiratory problems.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD